authors
- Sonpavde, GP
- Sternberg, CN
- Lee, J-L
- Emeribe, U
- Oh, SM
- Dantas De Lima, AR
- Hotte, Sebastien
1748P 4-factor model to predict response and survival benefit with durvalumab (D) in previously treated metastatic urinary tract carcinoma (mUTC)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2022
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal